eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
September 04, 2024 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing….